| 000 | 01879 a2200505 4500 | ||
|---|---|---|---|
| 005 | 20250515165305.0 | ||
| 264 | 0 | _c20090504 | |
| 008 | 200905s 0 0 eng d | ||
| 022 | _a0168-0102 | ||
| 024 | 7 |
_a10.1016/j.neures.2009.01.005 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aKumar, Puneet | |
| 245 | 0 | 0 |
_aNeuroprotective effect of cyclosporine and FK506 against 3-nitropropionic acid induced cognitive dysfunction and glutathione redox in rat: possible role of nitric oxide. _h[electronic resource] |
| 260 |
_bNeuroscience research _cApr 2009 |
||
| 300 |
_a302-14 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't | ||
| 650 | 0 | 4 |
_aAcetylcholinesterase _xmetabolism |
| 650 | 0 | 4 | _aAnalysis of Variance |
| 650 | 0 | 4 | _aAnimals |
| 650 | 0 | 4 |
_aArginine _xpharmacology |
| 650 | 0 | 4 |
_aBehavior, Animal _xdrug effects |
| 650 | 0 | 4 |
_aBrain _xdrug effects |
| 650 | 0 | 4 |
_aCognition Disorders _xchemically induced |
| 650 | 0 | 4 |
_aCyclosporine _xtherapeutic use |
| 650 | 0 | 4 | _aDose-Response Relationship, Drug |
| 650 | 0 | 4 | _aDrug Interactions |
| 650 | 0 | 4 |
_aEnzyme Inhibitors _xpharmacology |
| 650 | 0 | 4 |
_aGlutathione _xmetabolism |
| 650 | 0 | 4 |
_aGlutathione Transferase _xmetabolism |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 |
_aMaze Learning _xdrug effects |
| 650 | 0 | 4 |
_aNG-Nitroarginine Methyl Ester _xpharmacology |
| 650 | 0 | 4 |
_aNeuroprotective Agents _xtherapeutic use |
| 650 | 0 | 4 |
_aNitric Oxide _xmetabolism |
| 650 | 0 | 4 | _aNitro Compounds |
| 650 | 0 | 4 |
_aOxidative Stress _xdrug effects |
| 650 | 0 | 4 | _aPropionates |
| 650 | 0 | 4 | _aRats |
| 650 | 0 | 4 | _aRats, Wistar |
| 650 | 0 | 4 |
_aTacrolimus _xtherapeutic use |
| 650 | 0 | 4 | _aTime Factors |
| 700 | 1 | _aKumar, Anil | |
| 773 | 0 |
_tNeuroscience research _gvol. 63 _gno. 4 _gp. 302-14 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1016/j.neures.2009.01.005 _zAvailable from publisher's website |
| 999 |
_c18799883 _d18799883 |
||